Evidence map›Paper›PMID 38196657›Full record

ArticleResearch square2023

Antigen experience history directs distinct functional states of CD8+ CAR T cells during the anti-leukemia response.

Kole R DeGolier, Etienne Danis, Marc D'Antonio, Jennifer Cimons, Michael Yarnell, Ross M Kedl, M Eric Kohler, James P Scott-Browne, Terry J Fry

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Kole R DeGolierDepartment of Immunology, University of Colorado Anschutz Medical Campus; Aurora, CO, USA.ORCID 0000-0002-4144-7277
Etienne DanisBiostatistics and Bioinformatics Shared Resource, University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus; Aurora, CO, USA.
Marc D'AntonioDepartment of Immunology, University of Colorado Anschutz Medical Campus; Aurora, CO, USA.
Jennifer CimonsDepartment of Immunology, University of Colorado Anschutz Medical Campus; Aurora, CO, USA.ORCID 0000-0002-8111-8697
Michael YarnellDepartment of Pediatrics, University of Colorado Anschutz Medical Campus; Aurora, CO, USA.ORCID 0000-0002-4557-7255
Ross M KedlDepartment of Immunology, University of Colorado Anschutz Medical Campus; Aurora, CO, USA.ORCID 0000-0002-9065-7895
M Eric KohlerDepartment of Immunology, University of Colorado Anschutz Medical Campus; Aurora, CO, USA.
James P Scott-BrowneDepartment of Immunology, University of Colorado Anschutz Medical Campus; Aurora, CO, USA.
Terry J FryDepartment of Immunology, University of Colorado Anschutz Medical Campus; Aurora, CO, USA.
University of Colorado Anschutz Medical Campus · USChildren's Hospital Colorado · USNational Jewish Health · USUniversity of Colorado Cancer Center · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Transcriptional Control of T Cell FunctionR01AI151021 · NIAID · NATIONAL JEWISH HEALTH · PI SCOTT-BROWNE, JAMES · 2021 to 2025
$2.0M
NCI NIH HHS P30 CA046934NIAID NIH HHS R01 AI151021
6 · The paper itself

Abstract

Chimeric antigen receptor T cells are an effective therapy for B-lineage malignancies. However, many patients relapse and this therapeutic has yet to show strong efficacy in other hematologic or solid tumors. One opportunity for improvement lies in the ability to generate T cells with desirable functional characteristics. Here, we dissect the biology of CD8+ CAR T cells (CAR8) by controlling whether the T cell has encountered cognate TCR antigen prior to CAR generation. We find that prior antigen experience influences multiple aspects of

Identifiers

PMID38196657
PMCPMC10775394
OpenAlexW4390043695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.